Core Viewpoint - The company, Shangtai Technology, has announced plans to invest in a new project for the production of 200,000 tons of lithium-ion battery anode materials, with a total estimated investment of approximately 4.07 billion RMB [1] Group 1: Project Details - The second meeting of the second board of directors is scheduled for November 8, 2025, to review the investment agreement for the lithium-ion battery anode materials project [1] - The project will be developed in collaboration with the Shanxi Transformation Comprehensive Reform Demonstration Zone Management Committee and related entities [1] - The company may establish a new project company to manage the investment, utilizing its own or raised funds for the project [1]

Core Viewpoint - 尚太科技 is entering into an investment cooperation agreement for a lithium-ion battery anode material project in Shanxi, with a total estimated investment of approximately 4.07 billion yuan [1] Group 1: Project Details - The project will cover an area of approximately 955 acres and is expected to be operational within 14 months after obtaining construction land [1] - Funding for the project will come from the company's own or self-raised funds, with phased investments based on project planning and implementation progress [1] - The project aims to enhance the production capacity of high-performance, differentiated anode materials and strengthen strategic cooperation with core customers [1] Group 2: Industry Outlook - The company is optimistic about the future development of the lithium-ion battery and anode material industry, focusing on high-value-added, efficient, high-quality, and low-cost production capacity [2] - The lithium battery industry is experiencing good growth, driven by strong demand for power batteries from the domestic new energy vehicle market and rapid growth in global energy storage demand [3] - The company expects a balanced supply-demand situation in the fourth quarter, with potential upward pressure on anode material prices due to a tight supply-demand balance and rising raw material costs [3] Group 3: Financial Performance - In the first three quarters of the year, the company achieved revenue of 5.506 billion yuan, a year-on-year increase of 52.09%, and a net profit attributable to shareholders of 711 million yuan, up 23.08% [2] - The company reported significant growth in sales volume and revenue in the third quarter, benefiting from the recovery of the downstream market and the successful operation of its own production capacity [3]

Group 1 - The transaction does not constitute a related party transaction or a major asset restructuring as defined by the relevant regulations [1] - The project is driven by changes in major customer demand and is based on thorough market research [1] - Upon production, the project will enhance the company's capacity for high-performance, differentiated anode materials, deepen strategic cooperation with core customers, increase market share, and strengthen market position, thereby improving overall competitiveness [1] Group 2 - On November 8, the company held its 24th meeting of the second board of directors, approving the investment cooperation agreement for the "annual production of 200,000 tons of lithium-ion battery anode materials project" with the Shanxi Transformation Comprehensive Reform Demonstration Zone Management Committee and related units [3] - The company or its subsidiaries will establish a new project company to invest in the project within the Shanxi Transformation Comprehensive Reform Demonstration Zone, with a preliminary total investment estimated at approximately 4.07 billion yuan [3]

证券代码：001301 证券简称：尚太科技 公告编号：2025-121 石家庄尚太科技股份有限公司 关于公司向不特定对象发行可转换公司债券提交募集说明 书（注册稿）等申请文件的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 董事会 2025年11月11日 石家庄尚太科技股份有限公司（以下简称"公司"）向不特定对象发行可转 换公司债券的申请已于2025年11月6日获得深圳证券交易所上市审核委员会审核 通过，详见公司于2025年11月7日在巨潮资讯网（http://www.cninfo.com.cn）披露 的《关于向不特定对象发行可转换公司债券申请获得深圳证券交易所上市审核委 员会审核通过的公告》（公告编号:2025-117）。 根据本次发行事项实际进展以及相关审核要求，公司会同相关中介机构对申 请 文 件 内 容 进 行 了 更 新 和 修 订 , 具 体 内 容 详 见 公 司 同 日 在 巨 潮 资 讯 网 （http://www.cninfo.com.cn）披露的《石家庄尚太科技股份有限公司向不特定对 象发行可转换公司债券募集说明书（注册稿）》 ...

证券简称：尚太科技 证券代码：001301 石家庄尚太科技股份有限公司 （无极县里城道乡南沙公路西侧） 向不特定对象发行可转换公司债券 募集说明书 （注册稿） 保荐机构（主承销商） （深圳市罗湖区红岭中路 1012 号国信证券大厦十六层至二十六层） 二零二五年十一月 石家庄尚太科技股份有限公司 募集说明书 声 明 本公司及全体董事、监事、高级管理人员承诺募集说明书及其他信息披露资 料不存在任何虚假记载、误导性陈述或重大遗漏，并对其真实性、准确性及完整 性承担相应的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人保证募集说明书中财务 会计资料真实、完整。 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对申请 文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其对发行人的 盈利能力、投资价值或者对投资者的收益作出实质性判断或保证。任何与之相反 的声明均属虚假不实陈述。 根据《证券法》的规定，证券依法发行后，发行人经营与收益的变化，由发 行人自行负责。投资者自主判断发行人的投资价值，自主作出投资决策，自行承 担证券依法发行后因发行人经营与收益变化或者证券价格变动引致的投资风险。 1- ...

会杜律师事务所 ING&WODD K京市朝阳区东-环中 北京市金杜律师事务所 关于石家庄尚太科技股份有限公司 向不特定对象发行可转换公司债券 的法律意见书 致:石家庄尚太科技股份有限公司 北京市金杜律师事务所(以下简称金杜或本所)接受石家庄尚太科技股份有 限公司(以下简称尚太科技或发行人)的委托,担任发行人本次向不特定对象发 行可转换公司债券的中国境内专项法律顾问,根据《中华人民共和国证券法》(以 下简称《证券法》)、《中华人民共和国公司法》(以下简称《公司法》)、《上 市公司证券发行注册管理办法》(以下简称《注册管理办法》)、《律师事务所 从事证券法律业务管理办法》(以下简称《证券法律业务管理办法》)、《律师 事务所证券法律业务执业规则(试行)》(以下简称《证券法律业务执业规则》)、 《公开发行证券公司信息披露的编报规则第 12 号 -- 公开发行证券的法律意见书 和律师工作报告》(证监发[2001]37号)(以下简称《编报规则第12号》)等法 律、行政法规、部门规章、规范性文件和中国证券监督管理委员会(以下简称中 国证监会)的有关规定,按照律师行业公认的业务标准、道德规范和勤勉尽责精 神,就发行人本次发行 ...

国信证券股份有限公司 关于石家庄尚太科技股份有限公司 主板向不特定对象发行可转换公司债券的 发行保荐书 保荐人（主承销商） 第一节 本次证券发行基本情况 （深圳市罗湖区红岭中路1012号国信证券大厦十六层至二十六层） 保荐机构声明 本保荐机构及所指定的两名保荐代表人均是根据《中华人民共和国公司法》 （以下简称《公司法》）、《中华人民共和国证券法》（以下简称《证券法》）、《上 市公司证券发行注册管理办法》（以下简称《注册管理办法》）等有关法律、法规 和中国证券监督管理委员会（以下简称中国证监会）的有关规定，诚实守信，勤 勉尽责，严格按照依法制订的业务规则、行业执业规范和道德准则出具本发行保 荐书，并保证所出具的文件真实、准确、完整。 本发行保荐书中如无特别说明，相关术语或简称具有与《石家庄尚太科技股 份有限公司向不特定对象发行可转换公司债券募集说明书》中相同的含义。 3-1-1 | 四、本次发行符合《注册管理办法》和《<上市公司证券发行注册管理办法> | | --- | 一、保荐代表人情况 张宇女士：国信证券投资银行事业部业务董事，保荐代表人，法律硕士，具 有法律职业资格。2017 年进入国信证券投资银行事业部 ...

国信证券股份有限公司关于 石家庄尚太科技股份有限公司 主板向不特定对象发行可转换公司债券的 上市保荐书 保荐人（主承销商） （深圳市罗湖区红岭中路 1012 号国信证券大厦十六层至二十六层） | 十一、保荐机构对本次发行上市的推荐结论 20 | | --- | 本上市保荐书中如无特别说明，相关术语或简称具有与《石家庄尚太科技股 份有限公司向不特定对象发行可转换公司债券募集说明书》中相同的含义。 3-3-2 深圳证券交易所： 石家庄尚太科技股份有限公司（以下简称"尚太科技"、"发行人"或"公 司"）拟申请向不特定对象发行可转换公司债券。国信证券股份有限公司（以下 简称"国信证券"、"保荐人"）认为发行人符合《公司法》《证券法》《注册 管理办法》《深圳证券交易所股票上市规则》（以下简称"《上市规则》"）等 法律法规和中国证券监督管理委员会（以下简称"中国证监会"）及深圳证券交 易所的有关规定，同意向贵所保荐石家庄尚太科技股份有限公司申请向不特定对 象发行可转换公司债券。现将有关情况报告如下： 一、发行人基本情况 （一）发行人简介 保荐机构声明 本保荐机构及所指定的两名保荐代表人均是根据《中华人民共和国公司法》 （ ...

石家庄尚太科技股份有限公司 2022 年度审计报告 中国杭州市钱江新城新业路8号UDC时代大厦A座5-8层、12层、23层 Floors 5-8, 12 and 23. Block A. UDC Times Building, No. 8 Xinye Road. Qianjiang New City, Hangzhou Tel. 0571-88879999 Fax. 0571-88879000 www.zhcpa.cn -证明该审计报告是否由具有执业许可的会计师事务所出具, 您可使用手机"扫一扫"或进入"注册会 台 (http://acc 报告编码:浙23AEST 6-1-1 目 曼 | | 页 次 | | --- | --- | | 一、审计报告 | 1-5 | | 二、财务报表 | 6-17 | | (一) 合并资产负债表 | 6-7 | | (二) 合并利润表 | 8 | | (三) 合并现金流量表 | 9 | | (四) 合并所有者权益变动表 | 10-11 | | (五) 母公司资产负债表 | 12-13 | | (六) 母公司利润表 | 14 | | (七) 母公司现金流量表 | 15 | | ( ...

Group 1 - Shangtai Technology plans to invest approximately 4.07 billion RMB to establish a project for producing 200,000 tons of lithium-ion battery anode materials annually in Shanxi Province [1] - Chaoying Electronics' wholly-owned subsidiary intends to invest 1.468 billion RMB in Thailand to expand production of high-end printed circuit boards for AI computing power [1] - Zhongbei Communication signed a framework agreement worth 1 billion RMB with Hongxin Electronics for comprehensive computing power services over a period of 60 months [2] Group 2 - Hesheng Silicon Industry's shareholder, Fuda Industrial, plans to reduce its stake by up to 2.29%, amounting to a maximum of 27.07 million shares [3] - Victory Shares intends to acquire gas-related assets controlled by its major shareholder, with the stock resuming trading on November 11, 2025 [4] - Fangzhi Technology plans to acquire 100% of AI education company Zhixiang Technology for 116 million RMB, constituting a related party transaction [5] Group 3 - Ganfeng Lithium's PPGS lithium salt lake project has received an environmental impact assessment report, with approximately 15.07 million tons of LCE resources identified [6] - Puran Shares' shareholder is transferring 3.77% of the company's shares at a price of 106.66 RMB per share, which is a 38% discount compared to the closing price [7] - Shandong Gold's subsidiary needs to pay 738 million RMB in taxes, which is expected to impact the company's net profit for 2025 by 230 million RMB [8] Group 4 - Lingzhi Software is planning to acquire 100% of Kaimiride's shares, with the stock resuming trading on November 11, 2025 [8] - Maiwei Biotech's innovative drug 9MW3811 for pathological scars has received approval for a Phase II clinical trial, with significant global potential [8] - *ST Yuancheng received a notice of potential delisting due to its market capitalization falling below 500 million RMB for 20 consecutive trading days, with trading suspension starting November 11, 2025 [9]